PharmaCyte Biotech Inc (PMCB)

[frosr6]

And another failure... (Aptose) with none other Dr Von Hoff presiding.

Aptose Delays Lead Cancer Drug Development (APTO)
By Shobhit Seth | January 27, 2017 — 12:54 PM EST

http://www.investopedia.com/news/aptose-delays-lead-cancer-drug-development-apto/?lgl=rira-baseline-vertical


Aptose also appointed Daniel D. Von Hoff, M.D., to serve as a special advisor to fulfill the functions of the Company’s Senior Vice President of Medical Affairs. Dr. Von Hoff is an independent contractor and advisor but is not an employee of Aptose. The Board, after receiving the recommendation of a special committee composed of independent directors formed in September 2013 to review strategic alternatives available to the Company, designed to secure the long-term financial and operational sustainability of the Company with a view to enhance shareholder value, unanimously approved the appointments. In doing so, the Board determined that such appointments were in the best interest of Aptose, as they were considered to enhance the management team and advisory team with the addition of two seasoned and experienced biotechnology executives bringing extensive clinical development and capital raising experience and improving the awareness and presence of the Company in the United States.
https://www.sec.gov/Archives/edgar/data/882361/000117184317001838/f20f_032917.htm